Literature DB >> 15843543

Granzyme B binds to target cells mostly by charge and must be added at the same time as perforin to trigger apoptosis.

Lianfa Shi1, Dennis Keefe, Enrique Durand, Hanping Feng, Dong Zhang, Judy Lieberman.   

Abstract

Perforin (PFN) delivery of granzymes (Gzm) into the target cell at the immunological synapse is the major pathway for inducing apoptosis of virus-infected cells and tumors. A validated model for how PFN delivers Gzm into the cytosol is still lacking. PFN was originally thought to work by forming pores in the target cell plasma membrane that allow Gzm entry. This model was questioned when it was shown that GzmB is endocytosed without PFN. Moreover, apoptosis could be triggered by adding PFN to washed cells that have previously endocytosed GzmB. In this study, we show that GzmB binds to the plasma membrane mostly via nonspecific charge interactions. Washing in saline does not remove bound Gzm. However, if externally bound GzmB is completely removed, subsequent addition of PFN does not release previously endocytosed GzmB and does not trigger apoptosis. Therefore, PFN must be coendocytosed with GzmB to deliver it into the cytosol.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15843543     DOI: 10.4049/jimmunol.174.9.5456

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

Review 1.  Granzyme A activates another way to die.

Authors:  Judy Lieberman
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Immune-mediated loss of transgene expression from virally transduced brain cells is irreversible, mediated by IFNγ, perforin, and TNFα, and due to the elimination of transduced cells.

Authors:  Jeffrey M Zirger; Mariana Puntel; Josee Bergeron; Mia Wibowo; Rameen Moridzadeh; Niyati Bondale; Carlos Barcia; Kurt M Kroeger; Chunyan Liu; Maria G Castro; Pedro R Lowenstein
Journal:  Mol Ther       Date:  2012-01-10       Impact factor: 11.454

3.  Analysis of granulysin-mediated cytotoxicity in peripheral blood of patients with psoriatic arthritis.

Authors:  Drazen Massari; Larisa Prpic-Massari; Tatjana Kehler; Marija Kastelan; Bozidar Curkovic; Viktor Persic; Alen Ruzic; Gordana Laskarin
Journal:  Rheumatol Int       Date:  2011-08-10       Impact factor: 2.631

4.  Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate.

Authors:  Kirstin Veugelers; Bruce Motyka; Ing Swie Goping; Irene Shostak; Tracy Sawchuk; R Chris Bleackley
Journal:  Mol Biol Cell       Date:  2005-11-09       Impact factor: 4.138

Review 5.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

6.  In vivo polarization of IFN-gamma at Kupfer and non-Kupfer immunological synapses during the clearance of virally infected brain cells.

Authors:  Carlos Barcia; Kolja Wawrowsky; Robert J Barrett; Chunyan Liu; Maria G Castro; Pedro R Lowenstein
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

7.  The perforin pore facilitates the delivery of cationic cargos.

Authors:  Sarah E Stewart; Stephanie C Kondos; Antony Y Matthews; Michael E D'Angelo; Michelle A Dunstone; James C Whisstock; Joseph A Trapani; Phillip I Bird
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

8.  Knocking 'em Dead: Pore-Forming Proteins in Immune Defense.

Authors:  Xing Liu; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2020-01-31       Impact factor: 28.527

9.  Cationic sites on granzyme B contribute to cytotoxicity by promoting its uptake into target cells.

Authors:  Catherina H Bird; Jiuru Sun; Kheng Ung; Diana Karambalis; James C Whisstock; Joseph A Trapani; Phillip I Bird
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 10.  Direct microbicidal activity of cytotoxic T-lymphocytes.

Authors:  Paul Oykhman; Christopher H Mody
Journal:  J Biomed Biotechnol       Date:  2010-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.